November 7, 2011
Kissei Pharmaceutical’s consolidated sales rose 2.7% to ¥31,798 million due to good sales of the non-pharmaceutical segment. Sales in the pharmaceutical segment declined 0.5% to ¥27,750 million despite strong growth in sales of the treatment for dysuria Urief (silodosin) to...read more